Abstract

Objective: To find the recurrence and outcomes of giant cell tumors treated with scooping curettage, burr down technique, phenolization, and bone cement.Method: We conducted a descriptive case series using a non-probability consecutive sampling technique at the Department of Orthopedics, Lahore General Hospital, Lahore, Pakistan, from May 2014 to June 2018. A total of 40 patients aged between 20 to 40 years with Compannacci grade I, II & III giant cell tumors (GCT) were included and patients unfit for the surgery, those with multiple, recurrent, malignant giant cell tumors, tumors involving the axial skeleton, and previously treated cases were excluded. We recorded the side, site of the tumor, post-operative distal neurovascular status, and recurrence of giant cell tumors. The patients were follow-up in the out-patient department (OPD) at the second week, fourth week, 12th week, 24th week, 48th week, 96th week, and 144th week after the surgery. Side, site of the tumor, and post-operative distal neurovascular status were assessed clinically, and recurrence of the tumors was observed clinically and radiologically.Results: The mean age of all patients was 25.75±5.74 years. Males were 45% (18) and females were 55% (22). Most (12, 30%) tumors were present in the upper limb, and 22 (70%) were present in the lower limb. The majority (24, 60%) tumors were present around the knee joint. Companacci grade I was five (12.5%), grade II was 14 (35%), and grade III was 21 (52%). There were six (15%) pathological fractures. There was no case of distal neurovascular (DNV) injury, and three patients had a recurrence in two years of follow-up.Conclusion: Giant cell tumor treated with scooping curettage, burr down technique, phenolization and poly-methyl methacrylate showed 7.5% recurrence. The combined use of local adjuvants in the treatment of giant cell tumors is a safe and effective way to reduce the rate of local recurrence.

Highlights

  • Giant cell tumor (GCT) is a locally aggressive benign tumor of the bone

  • There was no case of distal neurovascular (DNV) injury, and three patients had a recurrence in two years of follow-up

  • We evaluated the distal neurovascular status of all patients after complete recovery from anesthesia

Read more

Summary

Introduction

Giant cell tumor (GCT) is a locally aggressive benign tumor of the bone. It affects the young adult population with a peak incidence occurring in the third decade of life and 70% of tumors reported between 20 and 40 years. It causes joint deformity due to bone destruction and may result in disability [1]. It represents approximately 20% of all benign bone tumors [2,3]. Females have a high incidence of GCTs. Approximately 60% of GCTs are localized around the knee joint. Due to their divergent biological behavior, they are generally locally aggressive, but few can metastasize to the lung or may transform into osteosarcoma or osteofibroma [4,5]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call